Accession Number:

ADA621020

Title:

A Randomized Phase 2 Trial of 177Lu Radiolabeled Anti-PSMA Monoclonal Antibody J591 in Patients with High-Risk Castrate, Biochemically Relapsed Prostate Cancer

Descriptive Note:

Annual rept. 17 Aug 2013-16 Aug 2014

Corporate Author:

CORNELL UNIV NEW YORK

Personal Author(s):

• Tagawa, Scott T.

Report Date:

2014-09-01

Pagination or Media Count:

35.0

Abstract:

Clinical trial has received WCMC IRB and CTSC approval with enrollment of initial 5 subjects at WCMC. An additional 33 subjects enrolled 28 treated at participating sub-sites. Reports submitted to WCMC DSMB in July 2014 with approval to proceed without modifications.

Descriptors:

• *CLINICAL TRIALS
• *IMMUNOTHERAPY
• *MONOCLONAL ANTIBODIES
• *PROSTATE CANCER
• *RADIOTHERAPY
• ANTIGENS

Subject Categories:

• Biochemistry
• Medicine and Medical Research
• Radiobiology
• Pharmacology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE